7.99USD
593.40 MUSD
2.95 BUSD
72.80 M
About West Pharmaceutical Services, Inc.
Sector
Industry
CEO
Eric Mark Green
Website
Headquarters
Exton
Employees (FY)
10.6 K
Founded
1923
ISIN
US9553061055
FIGI
BBG000BX24N8
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of WST is 377.36 USD — it has decreased by 0.56% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange West Pharmaceutical Services, Inc. stocks are traded under the ticker WST.
West Pharmaceutical Services, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
WST stock is 1.19% volatile and has beta coefficient of 1.29. Check out the list of the most volatile stocks — is West Pharmaceutical Services, Inc. there?
One year price forecast for West Pharmaceutical Services, Inc. has a max estimate of 470.00 USD and a min estimate of 355.00 USD.
WST earnings for the last quarter are 2.16 USD whereas the estimation was 1.86 USD which accounts for 16.34% surprise. Estimated earnings for the next quarter are 1.78 USD. See more details about West Pharmaceutical Services, Inc. earnings.
West Pharmaceutical Services, Inc. revenue for the last quarter amounts to 747.40 M USD despite the estimated figure of 750.31 M USD. In the next quarter revenue is expected to reach 739.46 M USD.
Yes, you can track West Pharmaceutical Services, Inc. financials in yearly and quarterly reports right on TradingView.
WST stock has fallen by 2.13% compared to the previous week, the month change is a 2.97% fall, over the last year West Pharmaceutical Services, Inc. has showed a 3.57% increase.
WST net income for the last quarter is 137.00 M USD, while the quarter before that showed 161.30 M USD of net income which accounts for −15.07% change. Track more West Pharmaceutical Services, Inc. financial stats to get the full picture.
Today West Pharmaceutical Services, Inc. has the market capitalization of 27.62 B, it has increased by 1.21% over the last week.
Yes, WST dividends are paid quarterly. The last dividend per share was 0.20 USD. As of today, Dividend Yield (TTM)% is 0.21%. Tracking West Pharmaceutical Services, Inc. dividends might help you take more informed decisions.
West Pharmaceutical Services, Inc. dividend yield was 0.22% in 2023, and payout ratio reached 9.90%. The year before the numbers were 0.31% and 9.57% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, WST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade West Pharmaceutical Services, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 10.60 K employees. See our rating of the largest employees — is West Pharmaceutical Services, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So West Pharmaceutical Services, Inc. technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating West Pharmaceutical Services, Inc. stock shows the buy signal. See more of West Pharmaceutical Services, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on West Pharmaceutical Services, Inc. future price: according to them, WST price has a max estimate of 470.00 USD and a min estimate of 355.00 USD. Read a more detailed West Pharmaceutical Services, Inc. forecast: see what analysts think of West Pharmaceutical Services, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. West Pharmaceutical Services, Inc. EBITDA is 853.80 M USD, and current EBITDA margin is 28.74%. See more stats in West Pharmaceutical Services, Inc. financial statements.